Skip to main content

Correction to: Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells

The Original Article was published on 02 December 2017

This article has been updated

Correction to: J Exp Clin Cancer Res 36, 172 (2017)

https://doi.org/10.1186/s13046-017-0635-9

Following publication of the original article [1], minor errors we identified in Fig. 6d and Fig. S4; specifically:

  • Figure 6d: incorrect image used for shCtrl scratch image (24 h); correct image now used

  • Fig. S4: incorrect images used for the invasive MDA-MB-231 cells (25 μM EA); correct images now used

Fig. 6
figure 1

ACTN4 promotes breast cancer proliferation and metastasis in vitro and in vivo. a Intracellular expression of ACTN4 was determined by Western blot (left) and real-time PCR (right) analysis, respectively; b ACTN4 expression was modified by transfecting recombinant plasmid or its shRNA in breast cancer cells and subjected to Western blotting (left) and real-time PCR (right) validation; c MTT and colony formation assay showed that ACTN4 silencing abrogated breast cancer cell proliferation while its overexpression promoted cell growth; d ACTN4 silencing inhibited the migration and invasion abilities of MDA-MB-231 cells; e ACTN4 silencing inhibited breast cancer growth and lung metastasis in vivo (*P < 0.05, **P < 0.01 versus control, values represented as the mean ± SD, n = 3)

The corrected figures, produced using the original data, are given here. The correction does not have any effect on the final conclusions of the paper.

Change history

  • 07 April 2022

    An amendment to this paper has been published and can be accessed via the original article.

Reference

  1. Wang N, Wang Q, Tang H, et al. Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells. J Exp Clin Cancer Res. 2017;36:172. https://doi.org/10.1186/s13046-017-0635-9.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Zhiyu Wang or Xiaoming Xie.

Supplementary Information

Additional file 4.

The wound healing and chamber invasive assay revealed that breast cancer cell migration and invasion were inhibited by EA in a time- and dose-dependent manner.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, N., Wang, Q., Tang, H. et al. Correction to: Direct inhibition of ACTN4 by ellagic acid limits breast cancer metastasis via regulation of β-catenin stabilization in cancer stem cells. J Exp Clin Cancer Res 41, 118 (2022). https://doi.org/10.1186/s13046-022-02341-1

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13046-022-02341-1